Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

Shanghai Jiao Tong University School of Medicine2,000 enrolled

Overview

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Hypertension, Resistant to Conventional Therapy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with resistant hypertension * age 18-65 years Exclusion Criteria: * known cause of hypertension * heart failure * renal dysfunction * Stroke, transient ischaemic attack or myocardial infarction in the past 6 months * cirrhosis * pregnancy * undertreatment of glucocorticoid

Locations (1)

Dep.endocrinology of Shanghai Ruijin Hospital, Shanghai Jiaotong university school of medcine

Shanghai, Shanghai Municipality, China

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.